Yu-hong Fu
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RAAS in diabetic retinopathy: mechanisms and therapies.
Journal: Archives of endocrinology and metabolism
Published: April 23, 2024
Brainstem auditory evoked potential in cognitive impairment in patients with type 2 diabetes mellitus.
Journal: Experimental gerontology
Published: January 15, 2021
Association Between Lipid Accumulation Product and Mild Cognitive Impairment in Patients with Type 2 Diabetes.
Journal: Journal of Alzheimer's disease : JAD
Published: August 18, 2020
MicroRNAs: Potential Targets in Diabetic Retinopathy.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: March 28, 2020
High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: February 15, 2020
Potential roles of Glucagon-like peptide-1 and its analogues in cognitive impairment associated with type 2 diabetes mellitus.
Journal: Mechanisms of ageing and development
Published: January 14, 2020
Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy.
Journal: Pharmacological research
Published: November 01, 2019
A new research hot spot: The role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications.
Journal: Life sciences
Published: September 03, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026